You have 9 free searches left this month | for more free features.

in Situ Breast Cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Invasive Breast Cancer, in Situ Breast Cancer Trial in Boston (Standard Genetic Counseling, Quantitative Genetic

Recruiting
  • Breast Cancer
  • +3 more
  • Standard Genetic Counseling
  • Quantitative Genetic Counseling
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 26, 2022

Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Female Trial (Control Arm ACSM Guidelines, Experimental Arm 6-12-25

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Control Arm ACSM Guidelines
  • Experimental Arm 6-12-25 repetitions per set
  • (no location specified)
Nov 6, 2023

Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

Not yet recruiting
  • Breast Atypical Hyperplasia
  • +3 more
  • Acolbifene Hydrochloride
  • +4 more
  • Duarte, California
  • +3 more
Jul 11, 2023

After Oncoplastic Breast Conserving Surgery

Not yet recruiting
  • Breast Cancer Stage I
  • +2 more
  • Breast-conserving surgery
  • (no location specified)
Feb 2, 2023

Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

Completed
  • Breast Atypical Ductal Hyperplasia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Standard Breast Cancer Risk Assessment for African American and

Not yet recruiting
  • Breast Atypical Ductal Hyperplasia
  • +3 more
  • Biospecimen Collection
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Feb 22, 2023

Breast Cancer Trial in Rozzano (external beams radiotherapy, brachytherapy)

Recruiting
  • Breast Cancer
  • external beams radiotherapy
  • brachytherapy
  • Rozzano, Milano, Italy
    IRCCS Istituto Clinico Humanitas
Jan 13, 2023

Ductal Carcinoma in Situ Trial (Tamoxifen, Exemestane, Letrozole)

Not yet recruiting
  • Ductal Carcinoma in Situ
  • (no location specified)
Oct 13, 2023

Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation

Active, not recruiting
  • Breast Cancer
  • +4 more
  • External Beam Radiation Therapy
  • +2 more
  • Richmond, Virginia
  • +1 more
Dec 16, 2022

BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

Not yet recruiting
  • BRCA Mutation
  • +3 more
  • Tamoxifen 10 Mg Tablet
  • +2 more
  • Genoa, Italy
  • +3 more
Sep 11, 2023

Breast Cancer - Ductal Carcinoma in Situ (DCIS), Breast-Conserving Surgery Trial (Histolog Scanner)

Not yet recruiting
  • Breast Cancer - Ductal Carcinoma in Situ (DCIS)
  • Breast-Conserving Surgery
  • Histolog Scanner
  • (no location specified)
Jul 6, 2023

Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +5 more
  • Intraoperative Imaging
  • Lumpectomy
  • Chicago, Illinois
  • +3 more
Nov 30, 2022

Breast Cancer, Carcinoma in Situ Trial in Kannur (Triage of clinical breast examination positive women using handheld ultrasound

Recruiting
  • Breast Cancer
  • Carcinoma in Situ
  • Triage of clinical breast examination positive women using handheld ultrasound by non-radiologists.
  • Kannur, India
    Malabar Cancer Care Society Kannur
Sep 28, 2023

MRI Characterization of Mammographically Detected DCIS

Recruiting
  • Breast Cancer, Stage 0
  • Breast MRI
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 21, 2022

Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer Trial in Mérida (Hypofractionated

Recruiting
  • Ductal Breast Carcinoma in Situ
  • +6 more
  • Hypofractionated radiotherapy
  • Mérida, Yucatán, Mexico
    Unidad Medica de Alta Especialidad
Nov 7, 2022

Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

Recruiting
  • Atypical Hyperplasia
  • Lobular Carcinoma in Situ
  • Evanston, Illinois
  • +1 more
Jan 20, 2023

Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +4 more
  • Non-Interventional Study
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 24, 2023

Breast Cancer, Ductal Carcinoma in Situ Trial in Basking Ridge, Commack, New York (MRI)

Active, not recruiting
  • Breast Cancer
  • Ductal Carcinoma in Situ
  • MRI
  • Basking Ridge, New Jersey
  • +2 more
Nov 7, 2022

Survival Rate of HER2-Low Breast Cancer Patients

Completed
  • HER2 Low Breast Carcinoma
  • immunohistochemistry (IHC) and in situ hybridization (ISH) Test
  • (no location specified)
Mar 2, 2023

Ductal Carcinoma in Situ Trial in Durham (Decision Support Tool with Active Monitoring, Decision Support Tool without Active

Completed
  • Ductal Carcinoma in Situ
  • Decision Support Tool with Active Monitoring
  • Decision Support Tool without Active Monitoring
  • Durham, North Carolina
    Duke Mammography Clinic
Jan 4, 2023

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma

Not yet recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +3 more
  • Accelerated Partial Breast Irradiation
  • Duarte, California
    City of Hope Medical Center
Aug 18, 2023

Early-stage Breast Cancer, Breast Carcinoma in Situ, Breast Tumors Trial in Santa Monica (Intraoperative Radiation Therapy

Recruiting
  • Early-stage Breast Cancer
  • +2 more
  • Intraoperative Radiation Therapy (IORT)
  • Santa Monica, California
    John Wayne Cancer Institute, Providence Saint John's Health Cent
Mar 18, 2022

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,

Active, not recruiting
  • Deleterious BRCA1 Gene Mutation
  • +5 more
  • Behavioral, Psychological or Informational Intervention
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Triple Negative Breast Cancer
  • +6 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
  • +1 more
Mar 8, 2023

Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

Active, not recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Metastatic Triple-negative Breast Cancer
  • ADV/HSV-tk
  • +3 more
  • Houston, Texas
    Houston Methodist Cancer Center
Dec 28, 2022